AMRN vs. LLY
AMRN (Amarin Corporation plc) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — AMRN in Biotechnology, LLY in Drug Manufacturers - General. Over the past 10 years, AMRN returned -13.89%/yr vs 32.12%/yr for LLY. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
AMRN vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMRN achieves a 2.19% return, which is significantly lower than LLY's 7.26% return. Over the past 10 years, AMRN has underperformed LLY with an annualized return of -13.89%, while LLY has yielded a comparatively higher 32.12% annualized return.
AMRN
- 1D
- 0.21%
- 1M
- -12.89%
- 6M
- -4.42%
- YTD
- 2.19%
- 1Y
- -5.94%
- 3Y*
- -15.70%
- 5Y*
- -29.66%
- 10Y*
- -13.89%
- ALL TIME*
- -18.30%
LLY
- 1D
- -0.53%
- 1M
- -5.36%
- 6M
- 11.14%
- YTD
- 7.26%
- 1Y
- 51.77%
- 3Y*
- 37.33%
- 5Y*
- 37.67%
- 10Y*
- 32.12%
- ALL TIME*
- 16.04%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $774.72K | $965.69K | $1.09M | |
| $2.62B | $2.84B | $3.35B |
AMRN vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMRN Amarin Corporation plc | 2.19% | 43.87% | -44.25% | -28.10% | -64.09% | -31.08% | -77.19% | 57.53% | 239.40% | 30.19% |
LLY Eli Lilly and Company | 7.26% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Correlation
The correlation between AMRN and LLY is 0.14, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.14 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 1993 | 0.09 |
Fundamentals
AMRN:
$294.94M
LLY:
$1.08T
AMRN:
-$0.23
LLY:
$28.16
AMRN:
9.42
LLY:
14.27
AMRN:
13.39
LLY:
32.99
AMRN:
$181.22M
LLY:
$72.25B
AMRN:
$77.40M
LLY:
$59.75B
AMRN:
-$24.61M
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMRN vs. LLY — Risk / Return Rank
AMRN
LLY
AMRN vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amarin Corporation plc (AMRN) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMRN | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.52 | ||
| Sortino ratioReturn per unit of downside risk | -1.83 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.28 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | 2.44 | -2.50 |
| Martin ratioReturn relative to average drawdown | -0.08 | 6.60 | -6.68 |
Loading charts...
Drawdowns
AMRN vs. LLY - Drawdown Comparison
The maximum AMRN drawdown since its inception was -99.97%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for AMRN and LLY.
Loading charts...
Drawdown Indicators
| AMRN | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -68.24% | -31.73% |
Max Drawdown (1Y)Largest decline over 1 year | -33.33% | -23.18% | -10.15% |
Max Drawdown (3Y)Largest decline over 3 years | -70.36% | -34.48% | -35.88% |
Max Drawdown (5Y)Largest decline over 5 years | -93.15% | -34.48% | -58.67% |
Max Drawdown (10Y)Largest decline over 10 years | -98.34% | -34.48% | -63.86% |
Current DrawdownCurrent decline from peak | -99.95% | -7.02% | -92.93% |
Average DrawdownAverage peak-to-trough decline | -90.44% | -19.17% | -71.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.15% | 8.56% | +14.59% |
Volatility
AMRN vs. LLY - Volatility Comparison
The current volatility for Amarin Corporation plc (AMRN) is 7.37%, while Eli Lilly and Company (LLY) has a volatility of 8.88%. This indicates that AMRN experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMRN | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.37% | 8.88% | -1.51% |
Volatility (6M)Calculated over the trailing 6-month period | 26.69% | 27.69% | -1.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.74% | 38.37% | +6.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.24% | 32.64% | +36.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 121.51% | 30.37% | +91.14% |
Dividends
AMRN vs. LLY - Dividend Comparison
AMRN has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMRN Amarin Corporation plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.56% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
AMRN vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Amarin Corporation plc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMRN vs. LLY - Profitability Comparison
AMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amarin Corporation plc reported a gross profit of 14.99M and revenue of 39.08M. Therefore, the gross margin over that period was 38.4%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
AMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amarin Corporation plc reported an operating income of -11.97M and revenue of 39.08M, resulting in an operating margin of -30.6%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
AMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amarin Corporation plc reported a net income of -7.65M and revenue of 39.08M, resulting in a net margin of -19.6%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
AMRN and LLY have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LLY has higher volatility (8.88%) compared to AMRN (7.37%). In terms of maximum drawdown, AMRN dropped -99.97% vs LLY's -68.24%.
LLY currently has the higher Sharpe Ratio (1.48 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMRN and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer